Moderna’s Covid-19 vaccine remains 93 per cent effective six months after the second dose, the US drugmaker said, as sales of the jab helped lift the company to a record quarterly profit.
The company’s coronavirus vaccine generated $4.2bn in second-quarter sales, Moderna said on Thursday, pushing it to a $2.8bn profit, in line with analysts’ expectations, from a $117m loss in the same period last year.
The US drugmaker reiterated its belief that booster shots will be needed later this year, despite the high six-month efficacy of its original two-dose Covid vaccine regimen.
您已閱讀24%（577字），剩余76%（1803字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。